Hypothalamic pathogenesis of type 2 diabetes

Medical Hypotheses

Volumn 67, Issue 2, 2006, Pages 307-310

  Koshiyama, Hiroyuki ^a,b   Hamamoto, Yoshiyuki ^a,b   Honjo, Sachiko ^a   Wada, Yoshiharu ^a   lkeda, Hiroki ^a,b  

^a Kitano Hospital   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM); GLUCOKINASE; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 2; LEPTIN; MALONYL COENZYME A; TRANSCRIPTION FACTOR CLOCK;

ARCUATE NUCLEUS; ARTICLE; BODY FAT; BRAIN; CIRCADIAN RHYTHM; CUSHING DISEASE; DYSLIPIDEMIA; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; HYDROCORTISONE RELEASE; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INSULIN DEPENDENCE; INSULIN RESISTANCE; LIVER; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OSTEOPOROSIS; PANCREAS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STRESS;

ADIPOGENESIS; ANIMALS; DIABETES MELLITUS, TYPE 2; GENE EXPRESSION REGULATION; GLUCOSE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; HYPOTHALAMUS; INSULIN RESISTANCE; MICE; PITUITARY-ADRENAL SYSTEM; TRANS-ACTIVATORS;

EID: 33744729005     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2006.02.033     Document Type: Article

References (33)

1. Bernard C. Leçons de physiologie expérimentale appliquéé å la médecine (1855), J.B. Bailliere et Dilis, Paris
2. Schwartz M.W., and Porte Jr. D. Diabetes, obesity, and the brain. Science 307 (2005) 375-379
3. Björntop P., Holm G., and Rosmond R. Hypothalamic arousal, insulin resistance and type 2 diabetes mellitus. Diabetic Med 16 (1999) 373-383
4. Chrousos G.P., and Gold P.W. Editorial: a healthy body in a healthy mind-and vice versa-the damaging power of "uncontrollable" stress. J Clin Endocrinol Metab 83 (1998) 1842-1845
5. Ruderman N.B., Saha A.K., Vavvas D., and Witters L.A. Malonyl-CoA, fuel sensing, and insulin resistance. Am J Physiol 276 (1999) E1-E18
6. Lynch R.M., Tompkins L.S., Brooks H.L., Dunn-Meynell A.A., and Levin B.E. Localization of glucokinase gene expression in the rat brain. Diabetes 49 (2000) 693-700
7. Minami K., Miki T., Kadowaki T., and Seino S. Roles of ATP-sensitive K+ channels as metabolic sensors: studies of Kir6.x null mice. Diabetes Suppl. 3 (2004) S176-S180
8. Wang R., Liu X., Hentges S.T., Dunn-Meynell A.A., Levin B.E., Wang W., et al. The regulation of glucose-excited neurons in the hypothalamic arcuate nucleus by glucose and feeding-relevant peptides. Diabetes 53 (2004) 1959-1965
9. Lam T.K.T., Gutierrez-Juarez R., Pocai A., and Rossetti L. Regulation of blood glucose by hypothalamic pyruvate metabolism. Science 309 (2005) 943-947
10. Miki T., Liss B., Minami K., Shiuchi T., Saraya A., Kashima Y., et al. ATP-sensitive K+ channels in the hypothalamus are essential for maintenance of glucose homeostasis. Nat Neurosci 4 (2001) 459-460
11. Cha S.H., Hu Z., Chohnan S., and Lane M.D. Inhibition of hypothalamic fatty acid synthetase triggers rapid activation of fatty acid oxidation in skeletal muscle. Proc Natl Acad Sci USA 102 (2005) 14557-14562
12. Loftus T.M., Jaworsky D.E., Frehywot G.L., Townsend G.A., Ronnett G.V., Lane M.D., et al. Reduced food intake and body weight in mice treated with fatty acid synthtase inhibitors. Science 288 (2000) 2379-2381
13. Bouchard C. Inhibition of food intake by inhibitors of fatty acid synthase. N Engl J Med 343 (2000) 1888-1889
14. Pocai A., Obici S., Schwartz G.J., and Rossetti L. A brain-liver circuit regulates glucose homeostasis. Cell Metab 1 (2005) 53-59
15. Minokoshi Y., Alquier T., Furukawa N., Kim Y.-B., Lee A., Xue B., et al. AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 428 (2004) 569-574
16. Namkoong C., Kim M.S., Jang P.G., Han S.M., Park H.S., Koh E.H., et al. Enhanced hypothalamic AMP-activated protein kinase activity contributes to hyperphagia in diabetic rats. Diabetes 54 (2005) 63-68
17. Porte Jr. D., Baskin D.G., and Schwartz M.W. Insulin signaling in the central nervous system. Diabetes 54 (2005) 1264-1276
18. Bruning J.C., Gautam D., Burks D.J., Gillette J., Schubert M., Orban P.C., et al. Role of brain insulin receptor in control of body weight and reproduction. Science 289 (2000) 2122-2125
19. Lin X., Taguchi A., Park S., Kushner J.A., Li F., Li Y., and White M.F. Dysregulation of insulin receptor substrate 2 in β cells and brain causes obesity and diabetes. J Clin Invest 114 (2004) 908-916
20. Kubota N., Terauchi T., Tobe K., Yano W., Suzuki R., Ueki K., et al. Insulin receptor substrate 2 plays a crucial role in β cells and the hypothalamus. J Clin Invest 114 (2004) 917-927
21. Choudhury A.I., Heffron H., Smith M.A., Al-Qassab H., Xu A.W., Selman C., et al. The role of insulin receptor substrate 2 in hypothalamic and β cell function. J Clin Invest 115 (2005) 940-950
22. Burks D.J., de Mora J.F., Schubert M., Withers D.J., Myers M.G., Towery H.H., et al. IRS-2 pathways integrate female reproduction and energy homeostasis. Nature 407 (2000) 377-382
23. Gribble F.M. Metabolism: a higher power for insulin. Nature 434 (2005) 965-966
24. Pocai A., Morgan K., Buettner C., Gutierrez-Juarez R., Obici S., and Rossetti L. Central leptin acutely reverses diet-induced hepatic insulin resistance. Diabetes 54 (2005) 3182-3189
25. Ikeda H, Yamada Y, Nagashima K, Tukiyama K, Kurose T, Todo T, et al. Clock gene defect dissociate energy metabolism from locomotor activity. Abstract of 64th ADA scientific meeting diabetes 2004;53(Suppl.):1554.
26. Turek F.W., Joshu C., Kohsaka A., Lin E., Ivanova G., McDearmon E., et al. Obesity and metabolic syndrome in circadian clock mutant mice. Science 308 (2005) 1043-1045
27. Shimba S., Ishii N., Ohta Y., Ohno T., Watabe Y., Hayashi M., et al. Brain and muscle Arnt-like protein-1 (BMAL1), a component of the molecular clock, regulates adipogenesis. Proc Natl Acad Sci USA 102 (2005) 12071-12076
28. Stern M.P. Diabetes and cardiovascular disease. The "common soil" hypothesis. Diabetes 44 (1995) 369-374
29. Koshiyama H., Honjo S., Hamamoto Y., Ikeda H., and Wada Y. Drugs share antidiabetic and antiathersclerotic actions though "the common soil". Med Hypotheses 66 (2006) 473-475
30. Matsuzawa Y. Adipocytokines and metabolic syndrome. Semin Vasc Med 5 (2005) 34-39
31. Plutzky J. Medicine, PPARs as therapeutic targets: reverse cardiology?. Science 302 (2003) 406-407
32. Koshiyama H. The impact of statin treatment on diabetic patients. Curr Opin Investig Drugs 4 (2003) 395-400
33. Koshiyama H., Ogawa Y., Tanaka K., and Tanaka I. The unified hypothesis of interactions among the bone, adipose and vascular systems: "osteo-lipo-vascular interactions". Med Hypotheses 66 (2006) 960-963